Characteristic | Frequency | Percentage | 95% CI |
---|---|---|---|
Age category | Â | Â | Â |
15–24 | 58 | 29.9 | 23.2–36.6 |
25–39 | 98 | 50.5 | 43.8–58.2 |
40–59 | 30 | 15.5 | 10.8–20.6 |
>=60 | 8 | 4.1 | 1.5–7.2 |
Sex | Â | Â | Â |
Male | 165 | 85.1 | 79.9–89.7 |
Female | 29 | 14.9 | 10.3–20.1 |
Residence | Â | Â | Â |
Rural | 64 | 33.0 | 26.3–39.7 |
Urban | 130 | 67.0 | 60.3–73.7 |
Other | 20 | 10.3 | 5.7–14.4 |
Time to presentation (min) Mean = 20.0, SD = 11.5, Min = 5.0, Max = 60.0 | |||
Within 30Â min | 168 | 86.6 | 82.0-91.2 |
Over 30 min | 26 | 13.4 | 8.8–18.0 |
Road user | Â | Â | Â |
Pedestrian | 74 | 38.1 | 31.4–44.8 |
Cyclist | 48 | 24.7 | 18.0-30.4 |
Driver | 16 | 8.2 | 4.6–12.4 |
Motorcycle passenger | 56 | 28.9 | 22.7–35.6 |
Cause of accident | |||
Driving/ riding errors | 115 | 59.3 | 51.5–66.0 |
Drug/ alcohol abuse | 37 | 19.1 | 13.9–24.7 |
Others | 42 | 21.6 | 16.0-27.8 |
Chronic medication | Â | Â | Â |
None | 148 | 76.3 | 70.6–82.0 |
Anticoagulants | 1 | 0.5 | 0.0-1.5 |
Steroids | 2 | 1.0 | 0.0-2.6 |
NSAIDs | 5 | 2.6 | 0.5–5.2 |
Other | 38 | 19.6 | 13.9–25.3 |
Comorbidity | Â | Â | Â |
None | 148 | 76.3 | 70.6–82.0 |
DM | 9 | 4.6 | 1.5–7.7 |
HTN | 11 | 5.7 | 2.6–9.3 |
DM + HTN | 6 | 3.1 | 1.0-5.7 |
HIV | 11 | 5.7 | 2.6–9.3 |
Other | 9 | 4.6 | 2.1–7.7 |
Head injury | Â | Â | Â |
No | 60 | 30.9 | 24.7–37.6 |
Yes | 134 | 69.1 | 62.4–75.3 |
Chest Injury | Â | Â | Â |
No | 140 | 72.2 | 66.0-78.4 |
Yes | 54 | 27.8 | 21.6–35.0 |
Abdomen and pelvis | Â | Â | Â |
No | 160 | 82.5 | 77.3–87.6 |
Yes | 34 | 17.5 | 12.4–22.7 |
Limb Injuries | Â | Â | Â |
No | 136 | 70.1 | 63.4–76.8 |
Yes | 58 | 29.9 | 23.2–36.6 |
Hospital | Â | Â | Â |
HRRH | 80 | 41.2 | 34.5–48.5 |
FRRH | 82 | 42.3 | 35.1–49.5 |
KIU-TH | 32 | 16.5 | 11.3–22.2 |